About Rebecca Crane

Rebecca Crane is a partner at Markwell Clarizio LLP who specialises in patent and drug regulatory work in the life sciences sector. She draws on her legal and scientific expertise to advise clients at all stages of health product development, as well as through the lifecycle of the products. Rebecca has significant expertise in litigation, regulatory and patent portfolio strategies in the areas of pharmaceuticals, life sciences and medical devices. She frequently represents life science industry clients in patent litigation matters and provides strategic product regulatory advice, including on matters related to Canada’s Patented Medicines Prices Review Board (PMPRB).